Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Factors such as sinusitis and aging, affects normal functioning of ear, nose and throat. ENT is one of the most important branches of medical science, also known as otolaryngology, which is focused on diagnosis and treatment of disorders associated with ear, nose, and throat. Dysfunction of these organs may affect the person’s quality of life. Disorders related to ENT are treated with the help of devices as well as various classes of drugs. The report mainly covers drug classes and medical devices used for the treatment of disease such as sinusitis, rhinitis, otitis media, tonsillitis, and others.
Market Dynamics
Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution. For instance, according to the World Health Organization 2015, over 4 million children die each year, globally due to environmental causes such as pollution and pollen grain infections. Several other factors contributing to the market growth includes, increasing R&D for drugs for treatment of ENT, and rising geriatric population and others. Rising awareness about the ENT treatments in emerging economies would increase the opportunities for market players to invest and capitalize in such regions. Asia Pacific is expected to witness significant traction in the global ENT disorder treatment market over the forecast period. This is owing to focus of key players on geographical expansion in the region and increasing R&D in ENT by various educational and research institutes in collaboration with local players. However, low awareness about the availability of treatments in some emerging economies such as several African countries as well as threat of developing antibiotic resistance are factors that are expected to hinder the market growth.
Key features of the study:
This report provides in-depth analysis of global ENT disorder treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global ENT disorder treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study Sanofi, AstraZeneca, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc., Merck & Co., Dr. Reddy’s Laboratories Ltd., Allergan plc, Cochlear Ltd., Sonova Holding AG, Siemens Healthcare, Starkey Laboratories Inc., William Demant Holding A/S, Widex A/S, GN ReSound A/S, Sonic Innovations Inc., Panasonic Corp., Beltone, Rexton Inc., Avada Hearing Care, Miracle-Ear Inc., MED-EL GmbH, Nuear Hearing Aids Inc., Audiosync Inc., Bernafon, American Hearing Systems Inc., Unitron Hearing Inc., and Zounds Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global ENT disorder treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the ENT disorder treatment market
Detailed Segmentation:
Global ENT Disorder Treatment Market, By Treatment Type:
By Devices
Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others
By Drugs
Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others
Global ENT Disorder Treatment Market, By Organ Type:
Ears
Nose
Throat
Global ENT Disorder Treatment Market, By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
Global ENT Disorder Treatment Market, By Geography:
North America
By Treatment Type:
By Devices
Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others
By Drugs
Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others
By Organ Type:
Ears
Nose
Throat
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
U.S.
Canada
Latin America
By Treatment Type:
By Devices
Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others
By Drugs
Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others
By Organ Type:
Ears
Nose
Throat
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Treatment Type:
By Devices
Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others
By Drugs
Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others
By Organ Type:
Ears
Nose
Throat
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Treatment Type:
By Devices
Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others
By Drugs
Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others
By Organ Type:
Ears
Nose
Throat
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Treatment Type:
By Devices
Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others
By Drugs
Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others
By Organ Type:
Ears
Nose
Throat
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Treatment Type:
By Devices
Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others
By Drugs
Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others
By Organ Type:
Ears
Nose
Throat
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Sanofi *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
AstraZeneca Plc
Novartis AG
Pfizer, Inc.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline Plc
Otonomy, Inc.
Merck & Co., Inc.
Reddy’s Laboratories Ltd.
Allergen Plc
Cochlear, Ltd.
Sonova Holdings AG
Siemens Healthineers
Starkey Laboratories, Inc.
William Demant Holdings A/S
Widex A/S
GN ReSound A/S
Sonic Innovations, Inc.
Panasonic Corporation
Beltone
Rexton, Inc.
Avada Hearing Care
Miracle-Ear, Inc.
MED-EL GmbH
Nuear Hearing Aids Inc.
AudioSync, Inc.
Bernafon
American Hearing Systems, Inc.
Unitron Hearing, Inc.
Zounds, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Treatment Type
? Market Snippet, By Organ Type
? Market Snippet, By End User
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Key Highlights
o Reimbursement Scenario
o Technological Advancements
o Recent FDA Approvals
o Regulatory Scenario
o PEST Analysis
o Epidemiology
4. Global ENT Disorder Treatment Market, By Treatment Type, 2017-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017-2025
? Segment Trends
o By Devices
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
? Segment Trends
• Hearing Aid Devices
• Voice Prostheses
• Nasal Splints
• Hearing Implants
• Others
o By Drugs
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
? Segment Trends
• Antibiotics
• Antihistamines
• Steroids
• Anti-inflammatory Drugs
• Others
5. Global ENT Disorder Treatment Market, By Organ Type, 2017-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017-2025
? Segment Trends
o Ears
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
o Nose
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
o Throat
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
6. Global ENT Disorder Treatment Market, By End User, 2017-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017-2025
? Segment Trends
o Hospitals
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
o Clinics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
o Ambulatory Surgical Centers
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
o Home Care Settings
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Million)
7. Global ENT Disorder Treatment Market, By Region, 2017-2025, (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2017-2025
o North America
? Market Size and Forecast, By Treatment Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By Organ Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By End User, 2017-2025, (US$ Million)
? Market Size and Forecast, By Country, 2017-2025, (US$ Million)
• U.S.
• Canada
o Latin America
? Market Size and Forecast, By Treatment Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By Organ Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By End User, 2017-2025, (US$ Million)
? Market Size and Forecast, By Country, 2017-2025, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Europe
? Market Size and Forecast, By Treatment Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By Organ Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By End User, 2017-2025, (US$ Million)
? Market Size and Forecast, By Country, 2017-2025, (US$ Million)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Treatment Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By Organ Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By End User, 2017-2025, (US$ Million)
? Market Size and Forecast, By Country, 2017-2025, (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
o Middle East
? Market Size and Forecast, By Treatment Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By Organ Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By End User, 2017-2025, (US$ Million)
? Market Size and Forecast, By Country, 2017-2025, (US$ Million)
• GCC
• Israel
• Rest of Middle East
o Africa
? Market Size and Forecast, By Treatment Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By Organ Type, 2017-2025, (US$ Million)
? Market Size and Forecast, By End User, 2017-2025, (US$ Million)
? Market Size and Forecast, By Country, 2017-2025, (US$ Million)
• South Africa
• Central Africa
• North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
? Sanofi*
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? AstraZeneca Plc
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Novartis AG
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Pfizer, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Mylan N.V.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Teva Pharmceutical Industries Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? GlaxoSmithKline Plc
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Otonomy, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Merck & Co., Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Dr. Reddy's Laboratories Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Allergen Plc
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Cochlear Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Sonova Holdings AG.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Siemens Healthineers
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Starkey Laboratories, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? William Demant Holdings, A/S
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Widex A/S
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? GN Re/Sound A/S
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Sonic Innovations. Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Panasonic Corporation
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Beltone
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Avada Hearing Care
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
? Miracle-Ear., Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
? MED-EL GmBH
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Nuear Hearing Aids, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? AudioSync, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Bernafon
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
? American Hearing Systems, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
? Unitron Hearing, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
? Zounds, Inc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Future Plans
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 42 market data tables and 36 figures on "ENT Disorder Treatment Market - Global forecast to 2025".
